Market Research Logo

Pharmacyclics Inc - Strategic SWOT Analysis Review

Pharmacyclics Inc - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Pharmacyclics Inc (Pharmacyclics), a wholly-owned subsidiary of AbbVie, discovers, develops and commercializes novel therapies for the treatment of cancer and immunemediated diseases. The company’s drugs and drug candidates are synthetic small-molecules that target major biochemical pathways that are associated with human diseases that have high unmet clinical need. It markets Imbruvica and has two drug candidates in clinical development and preclinical molecules in lead optimization. Imbruvica (ibrutinib), Pharmacyclics's first commercial product has been approved by the US FDA for the treatment of patients with mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL) and Waldenstrom’s macroglobulinemia (WM). Pharmacyclics is headquartered in Sunnyvale, California, the US.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Pharmacyclics Inc - Key Facts
Pharmacyclics Inc - Key Employees
Pharmacyclics Inc - Major Products and Services
Pharmacyclics Inc - History
Pharmacyclics Inc - Company Statement
Pharmacyclics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Pharmacyclics Inc - Business Description
Pharmacyclics Inc - Corporate Strategy
Pharmacyclics Inc - SWOT Analysis
SWOT Analysis - Overview
Pharmacyclics Inc - Strengths
Pharmacyclics Inc - Weaknesses
Pharmacyclics Inc - Opportunities
Pharmacyclics Inc - Threats
Pharmacyclics Inc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Pharmacyclics Inc, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Pharmacyclics Inc, Key Facts
Pharmacyclics Inc, Key Employees
Pharmacyclics Inc, Major Products and Services
Pharmacyclics Inc, History
Pharmacyclics Inc, Other Locations
Pharmacyclics Inc, Key Competitors
Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Pharmacyclics Inc, Recent Deals Summary
List of Figures
Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Pharmacyclics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report